Browse by author
Lookup NU author(s): Dr Daya Karat, Dr Ian Brotherick, Dr Brian Shenton, Dr Debbie Scott, Professor Michael Griffin
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
increased expression of oestrogen (ER) and progesterone (PR) receptors have been reported in gastric adenocarcinoma, although results have been variable. Immunohistochemical staining methodologies, in particular in the detection of ER, have been inconsistent with many tumours being classified ER-negative. In this study we have used flow cytometry to quantify expression of ER and PR in gastric adenocarcinoma and examine their relationships with established prognostic indicators. Cytokeratin-positive cells obtained from tumour biopsies of 50 patients with gastric cancer and ten control patients were labelled with biotinylated ER or PR antibodies followed by streptavidin PE. Flow cytometry was seen to increase the detection of ER levels in gastric cancer with more receptor-positive patients in this study than in results published to date. We believe this is related to the sensitivity of the flow cytometric assay with the detection of small shifts in ER level detected using cytokeratin gating. On analysis, the data showed no significant correlations with tumour stage and grade, and no differences were seen between normal mucosa and gastric cancer samples.
Author(s): Karat D, Brotherick I, Shenton BK, Scott D, Raimes SA, Griffin SM
Publication type: Article
Publication status: Published
Journal: British Journal of Cancer
Year: 1999
Volume: 80
Issue: 8
Pages: 1271-1274
Print publication date: 01/06/1999
ISSN (print): 0007-0920
ISSN (electronic): 1532-1827
Publisher: Nature Publishing Group
URL: http://dx.doi.org/10.1038/sj.bjc.6690497
DOI: 10.1038/sj.bjc.6690497
Altmetrics provided by Altmetric